Anixa Biosciences, Inc.ANIXNASDAQ
Loading
Asset Growth Recovery in ProgressRecovering
Percentile Rank41
Studio
Year-over-Year Change

Year-over-year total asset growth rate

Percentile
P41
Within normal range
vs 5Y Ago
-0.1x
Contraction
Streak
1 qtr
Consecutive growthRecovering
PeriodValue
Q1 2026-5.27%
Q4 2025-8.90%
Q3 20253.97%
Q2 2025-10.20%
Q1 2025-12.44%
Q4 2024-5.75%
Q3 2024-5.94%
Q2 2024-4.01%
Q1 2024-0.59%
Q4 2023-3.97%
Q3 2023-3.70%
Q2 2023-2.50%
Q1 2023-6.92%
Q4 2022-6.61%
Q3 2022-0.71%
Q2 2022-6.93%
Q1 2022-2.81%
Q4 2021-2.17%
Q3 2021-3.73%
Q2 2021163.60%
Q1 202154.50%
Q4 20200.97%
Q3 202058.01%
Q2 2020-3.88%
Q1 2020-2.06%
Q4 2019-8.02%
Q3 2019-11.88%
Q2 201920.02%
Q1 20190.34%
Q4 2018-11.59%
Q3 2018-0.92%
Q2 2018-1.73%
Q1 2018-15.00%
Q4 20174.73%
Q3 201716.07%
Q2 201771.85%
Q1 2017-25.04%
Q4 2016-10.97%
Q3 2016-12.27%
Q2 2016-16.67%